GeneDx Holdings
225 hedge funds and large institutions have $2.52B invested in GeneDx Holdings in 2025 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 86 increasing their positions, 59 reducing their positions, and 31 closing their positions.
147% more call options, than puts
Call options by funds: $62.7M | Put options by funds: $25.3M
87% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 31
46% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 59
39% more capital invested
Capital invested by funds: $1.81B → $2.52B (+$707M)
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
15.58% more ownership
Funds ownership: 85.66% → 101.24% (+16%)
13% more funds holding
Funds holding: 199 → 225 (+26)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$207M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$45M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$43.7M |
| 4 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$38.8M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$36.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.2M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$18.7M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$14M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$13.9M |
| 5 |
Renaissance Technologies
New York
|
-$11.7M |
WGS Hedge Fund Activity: Q1 2025 in Review
225 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q1 2025, worth a combined $2.52B — up 39% from $1.81B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new WGS positions and 31 closed out — a net gain of 27 holders — while 86 added to existing stakes and 59 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $207M. The largest seller was Lord, Abbett & Co, cutting an estimated $19.2M.
- 225 institutional investors held GeneDx Holdings (WGS) as of Q1 2025, up from 199 in Q4 2024.
- Funds reported $2.52B of GeneDx Holdings stock for Q1 2025, up 39% quarter-over-quarter.
- 58 funds opened new GeneDx Holdings positions in Q1 2025 and 31 closed out, a net change of +27 holders.
- The largest GeneDx Holdings buyer in Q1 2025 was Fidelity Investments, an estimated $207M added.
- The largest GeneDx Holdings seller in Q1 2025 was Lord, Abbett & Co, an estimated $19.2M sold.
Based on aggregated 13F filings for Q1 2025.